Medline Inc. (MDLN) accounting chief files initial insider ownership Form 3

Rhea-AI Filing Summary

Medline Inc. executive Jessi L. Corcoran, the company’s Principal Accounting Officer, has filed an initial statement of beneficial ownership of Medline stock on Form 3. This filing establishes her status as a reporting insider under SEC rules. The data provided shows no equity transactions at this time.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CORCORAN JESSI L

(Last) (First) (Middle)

C/O MEDLINE INC.

3 LAKES DRIVE

(Street)

NORTHFIELD IL 60093

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/24/2026

3. Issuer Name and Ticker or Trading Symbol
Medline Inc. [ MDLN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney.

No securities are beneficially owned.

	/s/ Nicole Fritz, Attorney-in-Fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Medline Inc. (MDLN) Form 3 filing by Jessi L. Corcoran mean?

The Form 3 filing shows Jessi L. Corcoran, Medline’s Principal Accounting Officer, is now an SEC-reporting insider. It formally records her beneficial ownership status in Medline Inc. securities and is typically required when a person first becomes an officer, director, or large shareholder.

Did Jessi L. Corcoran buy or sell any MDLN shares in this Form 3?

No transactions are reported in this Form 3 for Jessi L. Corcoran. The filing functions as an initial beneficial ownership statement, not a trade report, and the structured data shows zero buy, sell, acquire, or dispose transactions associated with this submission.

What is Jessi L. Corcoran’s role at Medline Inc. (MDLN) in this filing?

Jessi L. Corcoran is identified as an officer of Medline Inc., serving as Principal Accounting Officer. This senior finance role triggers SEC reporting obligations, so her beneficial ownership in Medline securities must be disclosed on Form 3 and updated on future Forms 4 or 5 if needed.

Does the Medline (MDLN) Form 3 filing indicate any major insider activity?

The Form 3 does not indicate major insider trading activity. It is an initial registration of insider status for Principal Accounting Officer Jessi L. Corcoran, with the transaction summary showing no reported purchases, sales, acquisitions, or dispositions in this particular filing.

How does this Form 3 filing affect Medline Inc. (MDLN) shareholders?

This Form 3 filing is largely administrative for shareholders. It confirms that Principal Accounting Officer Jessi L. Corcoran is now an SEC-reporting insider. It does not, by itself, signal changes in company strategy, capital structure, or operating performance for Medline Inc.